Patents
Patents for C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
10/2003
10/22/2003EP1353959A1 Surface-active photoinitiators
10/16/2003US20030195229 Administering viricides such as N-nonenyl glucosamine, and optionally with mixtures of nucleosides, nucleotides, immunomodulators or immunostimulants for prophylaxis viral diseases
10/15/2003EP1212316B1 Benzopyrans and benzothiopyrans as rar selective retinoid agonists
10/15/2003EP0766674B1 New hiv protease inhibitors
10/15/2003CN1124271C Process for preparing coumarin sulfonates
10/14/2003CA2291994C Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
10/09/2003WO2003082808A1 Benzamide derivatives
10/08/2003CN1446811A Method for preparing 2-trifluoromethyl-10-oxaneones
10/08/2003CN1123564C Anti-inflammatory compounds
10/07/2003US6630506 Useful as antianginal agents, and cardioprotective agents and for treating peripheral vascular disease including intermittent claudication
10/07/2003CA2223418C Polyoxyhydrocarbyl related products and methods for fluorescence assays
10/02/2003US20030187266 Non-nucleoside reverse transcriptase inhibitors
10/01/2003EP0960095B1 3-aminocarbonyl/3-aminothiocarbonyl-substituted 2-benzoyl- cyclohexan-1,3-diones with herbicidal effect
09/2003
09/25/2003WO2003078646A2 Aza-thioxanthenones with antitumor activity
09/25/2003WO2002030884A3 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
09/25/2003WO2002030882A3 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
09/25/2003US20030181511 For use as antiarrythmic medicaments with a cardioprotective component for prophylaxis of an infarction and therapy of infarction, and for treatment of angina pectoris
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003CN1443756A Bicyclic aromatic compound
09/23/2003CA2244196C Dihydrobenzofuran compounds useful as anti-inflammatory agents
09/18/2003US20030176420 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
09/17/2003CN1443160A N-substituted-1-amino-1,1-dialkyl carboxylic acid derivatives
09/17/2003CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities
09/16/2003CA2235421C Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/12/2003WO2003074509A1 Heterocycle-bearing onium salts
09/12/2003WO2003074475A2 Substituted aryl ketones
09/11/2003US20030171585 Anti-inflammatory compounds
09/11/2003US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements
09/11/2003US20030170561 An acid- dissociable group-containing polysiloxane and a photoacid generator containing a trifluoromethane sulfonic acid or other fluoroalkyl sulfonic acid compounds
09/10/2003CN1441796A Cyclic substituted aminomethyl compounds and medicaments containing said compounds
09/10/2003CN1120838C Dihydrobenzofuran compounds useful as anti-inflammatong agents
09/04/2003WO2003072568A1 Thioxanthone derivatives, and their use as cationic photoinitiators
09/04/2003WO2003072567A1 Novel fused ring compounds, and their use as cationic photoinitiators
09/04/2003US20030166708 Cyclic substituted aminomethyl compounds and medicaments comprising these compounds
09/03/2003CN1120162C Novel benzopyran derivatives
09/02/2003US6613917 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
09/02/2003US6613797 Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins
08/2003
08/28/2003WO2003008404A3 Sulfonium salts as phtoinitiators for radiation curable systems
08/28/2003US20030162814 Amines such as 2-(3-(N-hydroxyamidino)phenylamino)-N-(2'-sulfamoylbiphenyl-4-yl)-2 -methylpropionamide, used as anticoagulants or for prophylaxis of arteriosclerosis, angina pectoris, restinosis or metastasis
08/27/2003CN1438999A Serine protease inhibitors
08/27/2003CN1438543A Ring sulfonium and sulfonium oxide and photoacid generator and photoetching glue
08/26/2003US6610742 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
08/26/2003US6610733 Optically active chroman and thiochroman derivatives
08/21/2003US20030158178 Heterocyclic retinoid compounds
08/14/2003WO2003066620A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/14/2003CA2475093A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
08/13/2003EP1334096A1 Friedel-craft process for the preparation of thioxanthones
08/12/2003US6605747 Reacting the starting material, an alpha , alpha -difluorocyclohexylidene derivative with a halogen to produce an intermediate, reacting the intermediate with a phenol compound in presence of a base
08/12/2003US6605632 Affinity for melatonin receptors
08/06/2003CN1117070C Aryl or heteroaryl amides of tetrahydronahpthalene, chroman, thiochroman and 1,2,3-tetrahydroquinoline carboxylic acids having retinoid-like biological activity
08/05/2003US6603044 Phthalamide derivatives, or salt thereof agrohorticultural insecticide, and method for using the same
08/05/2003US6603012 RAR selective retinoid agonists
08/05/2003US6602903 Substituted heterocyclic compounds
08/05/2003US6602647 Sulfonium salt compound and resist composition and pattern forming method using the same
07/2003
07/31/2003WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
07/31/2003WO2003061660A1 Melanocortin receptor agonists
07/31/2003CA2473036A1 Melanocortin receptor agonists
07/30/2003CN1432873A Acid generating agent, sulfonic acid, sulfonic acid and radiation-sensitive resin composition
07/29/2003US6599861 Herbicides
07/24/2003US20030138664 Light emitting device material, light emitting device using thereof, and amine compound
07/23/2003CN1431203A 7-substitution-1-hero hydrogenated-2-ketone and ramification as well as its synthesizing method and usage
07/22/2003US6596758 Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
07/22/2003US6596743 Carbamic acid derivatives
07/22/2003US6596522 Compositions and optical methods for determining transmembrane potentials across plasma membrane of biological cells
07/22/2003US6596445 Initiators for photopolymerization of radically polymerizable compounds
07/22/2003CA2275166C Novel benzopyran derivatives
07/17/2003US20030135053 For use in human or veterinary conditions, that may be dermatological, rheumatic, respiratory, or cardiovascular and may be used in cosmetics
07/17/2003US20030134227 New photoacid generator compounds ("PAGs") are provided and photoresist compositions that comprise such compounds. In particular, cyclic sulfonium and sulfoxonium PAGs are provided. PAGs of the invention are particularly useful as
07/16/2003CN1430596A New gamma selective retinoids
07/15/2003CA2218766C Bicyclic-aromatic compounds
07/10/2003WO2003055873A1 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
07/10/2003WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
07/10/2003US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
07/10/2003US20030129670 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential
07/10/2003CA2467337A1 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
07/09/2003EP1324994A2 Tricyclic compounds and uses thereof
07/09/2003CN1429210A Substituted thioacetamides
07/08/2003CA2264372C New benzocyclobutane compounds, their method of preparation, and pharmaceutical compositions containing them
07/03/2003WO2003053955A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
07/03/2003US20030125571 7-hydroxy-3-(4-hydroxyphenyl)-3-methyl-chromene or thiochromene-4-yl)-pentafluoroalkanoic acid or a hydrate useful antiestrogenic or anticarcinogenic agent (breast cancer)
07/03/2003CA2448811A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
07/02/2003EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai
07/02/2003EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases
07/02/2003EP0980364B1 Process for preparing coumarin sulphonates
07/01/2003US6586460 Administering heterocyclic ethers or sulfides to induce apoptosis, cell differentiation and as anticarcinogenic agents
06/2003
06/26/2003WO2003051823A1 Beta-amino-alpha-cyanoacrylates and their use as herbicides
06/26/2003US20030120046 99m technetium, 188 and 186 rhenium chelated to 1-thio-d-glucose, glucosamine, or salts and hydrates thereof; tumor imaging agents
06/26/2003CA2470156A1 .beta.-amino-.alpha.-cyanoacrylates and their use as herbicides
06/25/2003CN1112343C Skin lightening compositions
06/24/2003US6583174 Bi-cyclic compound dissolved in a glyceride; 7-((1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo(4,3,0)nonane -8-one-7-yl)heptanoic acid
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114485 Killing drug resistant cancer cells; controlling cell differentiation
06/19/2003US20030114482 Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies
06/19/2003US20030113658 Contains fluoroalkyl groups; for use in a chemically amplified radiation-sensitive resin mixture, gives high transparency, no bioaccumulation, high acidity of produced acid, high boiling point, short diffusion length
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317441A1 Method for producing a cyclohexenone oxime ether lithium salt, products which can be obtained using this method, the use thereof and corresponding plant protection agents
06/11/2003EP1317426A1 Beta-thio-amino acids
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 48